Current Issues in nr-axSpA Diagnostics
Read More
What Should Highlight ACR 2021
The Psoriatic Patient's Role in Improving Care
The Modern Psoriatic Care Team
How Different Psoriatic Arthritis Manifestations Affect Care
Highlighted Psoriatic Arthritis Sessions at ACR 2020
Most Promising Psoriatic Arthritis
Achieving Individualized Psoriatic Arthritis Care
Fitting Biologics into the Psoriatic Arthritis Spectrum
Recent Achievements in Psoriatic Arthritis Management
SELECT-PsA 1 and SELECT-PsA 2 in Psoriatic Arthritis
Treating Enthesitis in Psoriatic Arthritis Patients: Filgotinib
Deucravacitinib for Active Psoriatic Arthritis
Guselkumab for Psoriatic Arthritis
Accurately Diagnosing Psoriatic Arthritis
Treatment Modification: ACR COVID-19 Guidelines
IL-6 Receptor Blockade in ICU Patients With COVID-19
Data on COVID-19 in Patients With Rheumatic Disease
Psoriatic Arthritis Treatment Factors: Comorbidities
Rheumatic Disease Challenges and Goals of Therapy
Managing Psoriatic Arthritis During COVID-19
Switching Therapies in PsA
Biologics in PsA: Monotherapy vs Combination Therapy
Impact of IL-23 Inhibitors on Pain and Fatigue in PsA
Safety and Efficacy of IL-23 Inhibitors for Treatment of PsA
DISCOVER-1/2 Trials in PsA
Approaching Treatment of Psoriatic Arthritis
Management of Psoriatic Arthritis With Biologics
Nonbiologics: Treatment of PsO and PsA
Goals of Therapy in Psoriasis and Psoriatic Arthritis